Td Waterhouse Canada Inc. Protalix Bio Therapeutics, Inc. Transaction History
Td Waterhouse Canada Inc.
- $14 Trillion
- Q2 2025
A detailed history of Td Waterhouse Canada Inc. transactions in Protalix Bio Therapeutics, Inc. stock. As of the latest transaction made, Td Waterhouse Canada Inc. holds 6,000 shares of PLX stock, worth $14,280. This represents 0.0% of its overall portfolio holdings.
Number of Shares
6,000
Previous 6,000
-0.0%
Holding current value
$14,280
Previous $15.2 Million
42.52%
% of portfolio
0.0%
Previous 0.0%
Shares
1 transactions
Others Institutions Holding PLX
# of Institutions
68Shares Held
8.67MCall Options Held
168KPut Options Held
31.4K-
Jim Simons Renaissance Technologies LLC | New York, Ny1.62MShares$3.84 Million0.0% of portfolio
-
Northern Trust Corp Chicago, IL1.08MShares$2.57 Million0.0% of portfolio
-
Geode Capital Management, LLC Boston, MA826KShares$1.97 Million0.0% of portfolio
-
Connor, Clark & Lunn Investment Management Ltd.496KShares$1.18 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA485KShares$1.15 Million0.0% of portfolio
About Protalix BioTherapeutics, Inc.
- Ticker PLX
- Exchange NYSE
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 49,753,400
- Market Cap $118M
- Description
- Protalix BioTherapeutics, Inc., a biopharmaceutical company, focuses on the development and commercialization of recombinant therapeutic proteins based on its proprietary ProCellEx plant cell-based protein expression system in the United States, Australia, Canada, Israel, Brazil, Russia, Turkey, and internationally. The company offers Elelyso fo...